NO147754C - Analogifremgangsmaate ved fremstilling av terapeutisk virksomme cefemderivater. - Google Patents
Analogifremgangsmaate ved fremstilling av terapeutisk virksomme cefemderivater.Info
- Publication number
- NO147754C NO147754C NO743205A NO743205A NO147754C NO 147754 C NO147754 C NO 147754C NO 743205 A NO743205 A NO 743205A NO 743205 A NO743205 A NO 743205A NO 147754 C NO147754 C NO 147754C
- Authority
- NO
- Norway
- Prior art keywords
- preparation
- therapeutically effective
- analogy procedure
- cefem derivatives
- cefem
- Prior art date
Links
Classifications
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D501/00—Heterocyclic compounds containing 5-thia-1-azabicyclo [4.2.0] octane ring systems, i.e. compounds containing a ring system of the formula:, e.g. cephalosporins; Such ring systems being further condensed, e.g. 2,3-condensed with an oxygen-, nitrogen- or sulfur-containing hetero ring
- C07D501/14—Compounds having a nitrogen atom directly attached in position 7
- C07D501/16—Compounds having a nitrogen atom directly attached in position 7 with a double bond between positions 2 and 3
- C07D501/20—7-Acylaminocephalosporanic or substituted 7-acylaminocephalosporanic acids in which the acyl radicals are derived from carboxylic acids
- C07D501/24—7-Acylaminocephalosporanic or substituted 7-acylaminocephalosporanic acids in which the acyl radicals are derived from carboxylic acids with hydrocarbon radicals, substituted by hetero atoms or hetero rings, attached in position 3
- C07D501/36—Methylene radicals, substituted by sulfur atoms
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D501/00—Heterocyclic compounds containing 5-thia-1-azabicyclo [4.2.0] octane ring systems, i.e. compounds containing a ring system of the formula:, e.g. cephalosporins; Such ring systems being further condensed, e.g. 2,3-condensed with an oxygen-, nitrogen- or sulfur-containing hetero ring
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D501/00—Heterocyclic compounds containing 5-thia-1-azabicyclo [4.2.0] octane ring systems, i.e. compounds containing a ring system of the formula:, e.g. cephalosporins; Such ring systems being further condensed, e.g. 2,3-condensed with an oxygen-, nitrogen- or sulfur-containing hetero ring
- C07D501/14—Compounds having a nitrogen atom directly attached in position 7
- C07D501/16—Compounds having a nitrogen atom directly attached in position 7 with a double bond between positions 2 and 3
- C07D501/20—7-Acylaminocephalosporanic or substituted 7-acylaminocephalosporanic acids in which the acyl radicals are derived from carboxylic acids
- C07D501/22—7-Acylaminocephalosporanic or substituted 7-acylaminocephalosporanic acids in which the acyl radicals are derived from carboxylic acids with radicals containing only hydrogen and carbon atoms, attached in position 3
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D501/00—Heterocyclic compounds containing 5-thia-1-azabicyclo [4.2.0] octane ring systems, i.e. compounds containing a ring system of the formula:, e.g. cephalosporins; Such ring systems being further condensed, e.g. 2,3-condensed with an oxygen-, nitrogen- or sulfur-containing hetero ring
- C07D501/14—Compounds having a nitrogen atom directly attached in position 7
- C07D501/16—Compounds having a nitrogen atom directly attached in position 7 with a double bond between positions 2 and 3
- C07D501/20—7-Acylaminocephalosporanic or substituted 7-acylaminocephalosporanic acids in which the acyl radicals are derived from carboxylic acids
- C07D501/24—7-Acylaminocephalosporanic or substituted 7-acylaminocephalosporanic acids in which the acyl radicals are derived from carboxylic acids with hydrocarbon radicals, substituted by hetero atoms or hetero rings, attached in position 3
- C07D501/26—Methylene radicals, substituted by oxygen atoms; Lactones thereof with the 2-carboxyl group
- C07D501/34—Methylene radicals, substituted by oxygen atoms; Lactones thereof with the 2-carboxyl group with the 7-amino radical acylated by carboxylic acids containing hetero rings
-
- Y—GENERAL TAGGING OF NEW TECHNOLOGICAL DEVELOPMENTS; GENERAL TAGGING OF CROSS-SECTIONAL TECHNOLOGIES SPANNING OVER SEVERAL SECTIONS OF THE IPC; TECHNICAL SUBJECTS COVERED BY FORMER USPC CROSS-REFERENCE ART COLLECTIONS [XRACs] AND DIGESTS
- Y02—TECHNOLOGIES OR APPLICATIONS FOR MITIGATION OR ADAPTATION AGAINST CLIMATE CHANGE
- Y02A—TECHNOLOGIES FOR ADAPTATION TO CLIMATE CHANGE
- Y02A50/00—TECHNOLOGIES FOR ADAPTATION TO CLIMATE CHANGE in human health protection, e.g. against extreme weather
- Y02A50/30—Against vector-borne diseases, e.g. mosquito-borne, fly-borne, tick-borne or waterborne diseases whose impact is exacerbated by climate change
Landscapes
- Chemical & Material Sciences (AREA)
- Organic Chemistry (AREA)
- Cephalosporin Compounds (AREA)
- Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
- Pyridine Compounds (AREA)
Applications Claiming Priority (2)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| DE2345402A DE2345402C3 (de) | 1973-09-08 | 1973-09-08 | 7-( 1 ^-DihydnM-oxo-1 -pyridylacetamido)-cephemderivate und Verfahren zu ihrer Herstellung |
| DE19742427224 DE2427224A1 (de) | 1974-06-06 | 1974-06-06 | Cephemderivate und verfahren zu ihrer herstellung |
Publications (3)
| Publication Number | Publication Date |
|---|---|
| NO743205L NO743205L (xx) | 1975-04-07 |
| NO147754B NO147754B (no) | 1983-02-28 |
| NO147754C true NO147754C (no) | 1983-06-08 |
Family
ID=25765762
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| NO743205A NO147754C (no) | 1973-09-08 | 1974-09-06 | Analogifremgangsmaate ved fremstilling av terapeutisk virksomme cefemderivater. |
Country Status (21)
| Country | Link |
|---|---|
| US (1) | US4153693A (xx) |
| JP (2) | JPS551274B2 (xx) |
| AR (3) | AR205799A1 (xx) |
| CA (1) | CA1072542A (xx) |
| CH (2) | CH605992A5 (xx) |
| CY (1) | CY970A (xx) |
| DD (1) | DD114268A5 (xx) |
| DK (1) | DK473974A (xx) |
| EG (1) | EG11821A (xx) |
| ES (2) | ES429864A1 (xx) |
| FR (1) | FR2242987B1 (xx) |
| GB (1) | GB1436989A (xx) |
| HK (1) | HK62878A (xx) |
| IL (1) | IL45488A (xx) |
| IT (1) | IT1106059B (xx) |
| KE (1) | KE2890A (xx) |
| MY (1) | MY7800442A (xx) |
| NL (1) | NL7411868A (xx) |
| NO (1) | NO147754C (xx) |
| SE (1) | SE433850B (xx) |
| YU (1) | YU36182B (xx) |
Families Citing this family (7)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| DE2507834A1 (de) * | 1975-02-24 | 1976-09-02 | Merck Patent Gmbh | Cephemderivate und verfahren zu ihrer herstellung |
| JPS55153791A (en) * | 1979-05-18 | 1980-11-29 | Sumitomo Chem Co Ltd | Novel beta-lactam compound |
| KR100841044B1 (ko) * | 2002-01-15 | 2008-06-25 | 주식회사 엔지켐 | 세팔로스포린 화합물의 제조 방법 |
| CN101584671B (zh) * | 2009-07-17 | 2011-03-16 | 山东罗欣药业股份有限公司 | 一种头孢西酮钠药物粉针剂以及头孢西酮钠原料药的合成方法 |
| CN104119361B (zh) * | 2014-07-10 | 2015-07-29 | 山东罗欣药业集团股份有限公司 | 一种新型抗生素化合物的精制方法 |
| CN104230958A (zh) * | 2014-08-22 | 2014-12-24 | 赵明亮 | 一种头孢西酮的制备方法 |
| CN106967092B (zh) * | 2017-04-12 | 2019-05-03 | 山东裕欣药业有限公司 | 一种头孢西酮的制备方法 |
Family Cites Families (5)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| US3218318A (en) * | 1962-08-31 | 1965-11-16 | Lilly Co Eli | 7-heterocyclic-substituted-acylamido cephalosporins |
| US3833570A (en) * | 1970-08-12 | 1974-09-03 | Bristol Myers Co | 7-(3-substituted-1,2,4-oxadiazole-5-one-4-acetamido)cephalosporanic acids and derivatives thereof |
| US3956288A (en) * | 1973-11-07 | 1976-05-11 | Richardson-Merrell Inc. | 7-[(2,4-Dioxo-1-pyrimidinyl)acylamino]cephalosporin derivatives |
| US3956287A (en) * | 1973-11-07 | 1976-05-11 | Richardson-Merrell Inc. | 7-[(2-Oxo-1-pyridinyl)acylamino]cephalosporin derivatives |
| US4119775A (en) * | 1974-09-27 | 1978-10-10 | Richardson-Merrell Inc. | 4-Oxo-1-pyridinyl cephalosporin derivatives |
-
1974
- 1974-01-01 AR AR255292A patent/AR205799A1/es active
- 1974-08-19 IL IL45488A patent/IL45488A/en unknown
- 1974-09-04 CH CH1425177A patent/CH605992A5/xx not_active IP Right Cessation
- 1974-09-04 SE SE7411162A patent/SE433850B/xx unknown
- 1974-09-04 CH CH1202874A patent/CH605993A5/xx not_active IP Right Cessation
- 1974-09-05 YU YU2404/74A patent/YU36182B/xx unknown
- 1974-09-05 CY CY970A patent/CY970A/xx unknown
- 1974-09-05 GB GB3883374A patent/GB1436989A/en not_active Expired
- 1974-09-06 NO NO743205A patent/NO147754C/no unknown
- 1974-09-06 JP JP10341274A patent/JPS551274B2/ja not_active Expired
- 1974-09-06 DK DK473974A patent/DK473974A/da not_active Application Discontinuation
- 1974-09-06 NL NL7411868A patent/NL7411868A/xx not_active Application Discontinuation
- 1974-09-06 US US05/503,705 patent/US4153693A/en not_active Expired - Lifetime
- 1974-09-06 CA CA208,630A patent/CA1072542A/en not_active Expired
- 1974-09-06 FR FR7430268A patent/FR2242987B1/fr not_active Expired
- 1974-09-06 DD DD180964A patent/DD114268A5/xx unknown
- 1974-09-07 ES ES429864A patent/ES429864A1/es not_active Expired
- 1974-09-07 EG EG375/74A patent/EG11821A/xx active
-
1975
- 1975-01-01 AR AR258047A patent/AR208079A1/es active
- 1975-03-20 AR AR258048A patent/AR202261A1/es active
- 1975-10-30 ES ES442217A patent/ES442217A1/es not_active Expired
-
1976
- 1976-09-09 JP JP51108668A patent/JPS5253866A/ja active Granted
-
1978
- 1978-10-11 KE KE2890A patent/KE2890A/xx unknown
- 1978-10-26 HK HK628/78A patent/HK62878A/xx unknown
- 1978-10-30 IT IT51703/78A patent/IT1106059B/it active
- 1978-12-30 MY MY442/78A patent/MY7800442A/xx unknown
Also Published As
| Publication number | Publication date |
|---|---|
| US4153693A (en) | 1979-05-08 |
| IL45488A0 (en) | 1974-11-29 |
| IT1106059B (it) | 1985-11-11 |
| EG11821A (en) | 1977-12-31 |
| ES429864A1 (es) | 1977-01-01 |
| FR2242987A1 (xx) | 1975-04-04 |
| CH605993A5 (xx) | 1978-10-13 |
| DK473974A (xx) | 1975-05-05 |
| JPS614833B2 (xx) | 1986-02-13 |
| ES442217A1 (es) | 1977-07-01 |
| IT7851703A0 (it) | 1978-10-30 |
| AU7243474A (en) | 1976-02-19 |
| HK62878A (en) | 1978-11-03 |
| NO147754B (no) | 1983-02-28 |
| AR208079A1 (es) | 1976-11-30 |
| DD114268A5 (xx) | 1975-07-20 |
| NO743205L (xx) | 1975-04-07 |
| NL7411868A (nl) | 1975-03-11 |
| YU36182B (en) | 1982-02-25 |
| YU240474A (en) | 1981-06-30 |
| CY970A (en) | 1978-12-22 |
| JPS5053392A (xx) | 1975-05-12 |
| JPS551274B2 (xx) | 1980-01-12 |
| CH605992A5 (xx) | 1978-10-13 |
| AR202261A1 (es) | 1975-05-23 |
| JPS5253866A (en) | 1977-04-30 |
| MY7800442A (en) | 1978-12-31 |
| SE433850B (sv) | 1984-06-18 |
| CA1072542A (en) | 1980-02-26 |
| IL45488A (en) | 1977-10-31 |
| FR2242987B1 (xx) | 1977-11-04 |
| AR205799A1 (es) | 1976-06-07 |
| SE7411162L (xx) | 1975-03-10 |
| KE2890A (en) | 1978-10-27 |
| GB1436989A (en) | 1976-05-26 |
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| NO143940C (no) | Fremgangsmaate ved fremstilling av alfa-l-aspartyl-l-fenyl-alaninalkylestere | |
| NO141407C (no) | Analogifremgangsmaate ved fremstilling av terapeutisk aktive etylenderivater | |
| NO144850C (no) | Analogifremgangsmaate til fremstilling av immunpotenserende glukosaminderivater. | |
| NO145576C (no) | Analogifremgangsmaate ved fremstilling av terapeutisk aktive penicillinderivater | |
| NO149281C (no) | Analogifremgangsmaate til fremstilling av terapeutisk aktive 7alfa-metoksycephalosporinderivater | |
| NO152751C (no) | Analogifremgangsmaate ved fremstilling av et terapeutisk virksomt cephalosporinderivat. | |
| NO142894C (no) | Fremgangsmaate ved fremstilling av polyethylenterefthalatfilm | |
| NO142303C (no) | Analogifremgangsmaate til fremstilling av terapeutisk virksomme oksazolderivater | |
| NO141755C (no) | Analogifremgangsmaate til fremstilling av terapeutisk virksomme dotriacontapeptidamider | |
| NO741125A (no) | Analogifremgangsmåte ved fremstilling av terapeutisk aktive pyrido-pyrimidin-derivater. | |
| NO146596C (no) | Fremgangsmaate for fremstilling av 6-deoksytetracykliner | |
| NO142221C (no) | Analogifremgangsmaate ved fremstilling av antibakterielt virksomme piperazinderivater | |
| NO142260C (no) | Analogifremgangsmaate ved fremstilling av terapeutisk aktive tienotriazolodiazepinderivater | |
| NO790627L (no) | Fremgangsmaate for fremstilling av hydroksyalkylxantiner | |
| NO153806C (no) | Fremgangsmaate for fremstilling av 6-deoksytetracyklin. | |
| SE417319B (sv) | Analogiforfarande for framstellning av ergopeptiner | |
| SE7608956L (sv) | Forfarande for framstellning av 2-(fenoxialkyltio)-5-nitroimidazoler | |
| NO147754C (no) | Analogifremgangsmaate ved fremstilling av terapeutisk virksomme cefemderivater. | |
| NO144039C (no) | Analogifremgangsmaate ved fremstilling av nye, terapeutisk virksomme benzofuranderivater | |
| NO153221C (no) | Analogifremgangsmaate for fremstilling av terapeutisk virksomme 6-metoksy-alfa-karboksypenicilliner. | |
| SE401835B (sv) | Forfarande for framstellning av 17beta-hydroxi-16,16-dimetylest-4-en-3-on | |
| NO740779L (no) | Analogifremgangsmåte til fremstilling av terapeutisk virksomme 6-substituerte 3-karbetoksyhydrazinopyridaziner. | |
| NO741309L (no) | Analogifremgangsmåte ved fremstilling av terapeutisk aktive seco-prostaglandiner. | |
| NO144068C (no) | Fremgangsmaate ved fremstilling av butyrofenonderivater | |
| NO142909C (no) | Analogifremgangsmaate ved fremstilling av terapeutisk aktive 4-benzazoninderivater |